Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index

BACKGROUND AND AIMS: Chronic hepatitis B patients in Taiwan with no or limited liver injury are not reimbursed for antiviral treatment by the Taiwan National Health Insurance (NHI). Innovative fibrosis marker, age-adjusted Fibrosis-4 Index (FIB4-AA), was implemented to evaluate the tendency of liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ta-Wei, Huang, Chung-Feng, Yeh, Ming-Lun, Tsai, Pei-Chien, Jang, Tyng-Yuan, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745320/
https://www.ncbi.nlm.nih.gov/pubmed/33323472
http://dx.doi.org/10.1136/bmjgast-2020-000543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745320/
https://www.ncbi.nlm.nih.gov/pubmed/33323472
http://dx.doi.org/10.1136/bmjgast-2020-000543

Ejemplares similares